IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test
IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test
Read moreFri, 20th Jan 2017 10:17
IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test
Read more(Sharecast News) - Biotherapeutics company Avacta Group announced on Monday that it will launch an 'ELISA' laboratory test for the SARS-CoV-2 spike protein, to support global research efforts into the coronavirus that causes Covid-19.
Read moreIN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity
Read more(Sharecast News) - Biotherapeutics company Avacta Group has entered into an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test, it announced on Wednesday, as part of its ongoing expansion of manufacturing capacity.
Read moreAvacta Expands Development Agreement With LG Chem Life Sciences
Read moreIN BRIEF: Avacta Not Involved With Medusa 19's Covid Antibody Test
Read moreIN BRIEF: Avacta Names New Life Sciences Chief Development Officer
Read more(Sharecast News) - Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine (LSTM), it announced on Friday, to clinically validate the rapid saliva-based coronavirus antigen test it is developing with Cytiva.
Read moreUK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance
Read moreAvacta Collaborates With Liverpool School For Covid-19 Test Validation
Read moreIN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit
Read more(Sharecast News) - Biotechnology company Avacta on Thursday appointed BBI Solutions as a manufacturing partner for the development of its rapid SARS-CoV-2 antigen test.
Read moreIN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical
Read more(Sharecast News) - Biotherapeutics and reagents developer Avacta Group announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics - the joint venture established in South Korea by the two companies - to develop stem cell treatments on Wednesday.
Read moreUK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost
Read more